Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADIL Adial Pharmaceuticals

Market Closed 10-23 16:00:00 EDT

3.92

-0.30

-7.11%

盘后3.92

+0.000.00%

16:10 EDT

High4.28	Low3.92	Vol47.36K
Open4.15	D1 Closing4.22	Amplitude8.53%
Mkt Cap10.29M	Tradable Cap9.57M	Total Shares2.63M
T/O195.91K	T/O Rate1.94%	Tradable Shares2.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":3.92,"timestamp":1792785600000,"preClose":4.22,"halted":0,"volume":47359,"hourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.92,"latestTime":"16:10 EDT","volume":4,"amount":15.68,"timestamp":1792786204638,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07109004739336489,"floatShares":2440070,"shares":2625900,"eps":-17.71,"marketStatus":"Market Closed","change":-0.3,"latestTime":"10-23 16:00:00 EDT","open":4.15,"high":4.28,"low":3.92,"amount":195912,"amplitude":0.085308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-17.71,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":4.22,"preHourTrading":{"tag":"盘前","latestPrice":4.5,"preClose":4.22,"latestTime":"04:00 EDT","volume":11,"amount":49.5,"timestamp":1792742402746,"change":0.28,"changeRate":0.066351,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.92,"latestTime":"16:10 EDT","volume":4,"amount":15.68,"timestamp":1792786204638,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.351419525439003,"impliedVol":1.6275,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADIL/wiki","defaultTab":"wiki","newsList":[{"id":"2677627402","title":"Adial Pharmaceuticals Publishes Revised Quarterly Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2677627402","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677627402?lang=en_us&edition=fundamental","pubTime":"2026-10-21 18:04","pubTimestamp":1792577049,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Publishes Revised Quarterly Financial ReportAdial Pharmaceuticals published a revised quarterly financial report for the period ended June 30, 2026.Disclaimer:This news brief was","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL7LGk8X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676351276","title":"Adial Pharmaceuticals Adjourns Meeting Pending Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2676351276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676351276?lang=en_us&edition=fundamental","pubTime":"2026-10-17 05:51","pubTimestamp":1792187503,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) has shared an announcement. Adial Pharmaceuticals convened its 2026 Annual Meeting of Stockholders on September 1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-adjourns-meeting-pending-nasdaq-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-adjourns-meeting-pending-nasdaq-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","BK4007","ADIL","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676051280","title":"Adial Pharmaceuticals Delays Shareholder Meeting to Oct. 26 Pending NASDAQ Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2676051280","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676051280?lang=en_us&edition=fundamental","pubTime":"2026-10-17 05:16","pubTimestamp":1792185371,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Delays Shareholder Meeting to Oct. 26 Pending Nasdaq ApprovalAdial Pharmaceuticals further adjourned its 2026 annual shareholder meeting to October 26 at 8:30 a.m. Eastern Time, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL961VVL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675596025","title":"Adial Pharmaceuticals Appoints David Rubenstein as Chief Scientist","url":"https://stock-news.laohu8.com/highlight/detail?id=2675596025","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675596025?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:02","pubTimestamp":1792148527,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Appoints David Rubenstein as Chief ScientistAdial Pharmaceuticals appointed David Rubenstein as chief scientist to lead its research and scientific strategy.Rubenstein previously","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL9G2mpB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014021.USD","BCDF","BK4588","IE00BKPKM429.USD","NDAQ","IE00BQXX3F31.USD","SG9999014013.SGD","BK4585","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","ADIL","BK4007","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749339","title":"Adial Pharmaceuticals Delays Shareholder Meeting Vote on Proposals 3-6 to Oct. 15 Pending NASDAQ Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749339","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749339?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:17","pubTimestamp":1790972229,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals delays shareholder meeting vote on proposals 3-6 to Oct. 15 pending Nasdaq approvalAdial Pharmaceuticals delayed votes on four shareholder proposals tied to a Nasdaq initial list","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL8CRsmW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672780615","title":"Adial Pharmaceuticals Grants New-Hire Stock Option for 155,446 Shares at $4.22 Exercise Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2672780615","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672780615?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:46","pubTimestamp":1790804780,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals grants new-hire stock option for 155,446 shares at $4.22 exercise priceAdial Pharmaceuticals granted a new-employee stock option covering 155,446 common shares.Exercise price set","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL3MNWZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","BCDF","IE00BQXX3D17.EUR","SG9999014021.USD","ADIL","BK4588","BK4007","SG9999014039.USD","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672618780","title":"Adial Pharmaceuticals Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672618780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672618780?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:46","pubTimestamp":1790804769,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA4D1ZTC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672778043","title":"Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672778043","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672778043?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:46","pubTimestamp":1790804760,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., Sept.  30, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new e","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3372449/0/en/adial-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","LCLG","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973665","title":"Adial Pharmaceuticals Holds Annual Shareholder Meeting, Quorum Present","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973665","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973665?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:27","pubTimestamp":1789763269,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals holds annual shareholder meeting, quorum presentAdial Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 17, 2026.Shareholders adopted an amendment to the 2017 Equ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL98Cbd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936979","title":"Adial Pharmaceuticals Amends Agreements to Restore Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936979","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936979?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:29","pubTimestamp":1789594155,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) has shared an update. Adial Pharmaceuticals disclosed that accounting treatment of Milestone Warrants linked to i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-amends-agreements-to-restore-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-amends-agreements-to-restore-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4007","LCLG","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667812159","title":"ADB Approves Rp11.5 Trillion Loan for Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2667812159","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667812159?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:25","pubTimestamp":1789557937,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Asian Development Bank  has approved a US$650 million loan program, equivalent to Rp11.5 trillion, to assist Indonesia in modernizing regional fiscal management, advancing digital governance, and improving public service delivery.Under the Accelerating Decentralization for Improved Local Governance  subprogram, ADB's financing facility aims to strengthen coordination between the central and regional governments in managing public funds.“This program will support a new national digital platform for fiscal data integration and reporting, alongside equitable property tax assessments to boost regional revenue,” ADB Country Director for Indonesia Bobur Alimov said in a statement in Jakarta on Wednesday, September 16, 2026, as reported by news agency Antara.","market":"hk","thumbnail":"https://statik.tempo.co/data/2026/09/16/id_1489257/1489257_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/09/16/id_1489257/1489257_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2119715/adb-approves-rp11-5-trillion-loan-for-indonesia","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2119715/adb-approves-rp11-5-trillion-loan-for-indonesia","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663401562","title":"Adial Pharmaceuticals files to sell 25.15M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2663401562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663401562?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:55","pubTimestamp":1787950509,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 25.15M shares of common stock. The company is not ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-files-to-sell-25-15m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-files-to-sell-25-15m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663515015","title":"Adial Pharmaceuticals - Proposed Resale of up to 25,148,970 Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2663515015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663515015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:49","pubTimestamp":1787950189,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P1U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662799054","title":"Adial Pharma Grants Unregistered Option for 307,814 Shares at $5.76 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662799054","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662799054?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:05","pubTimestamp":1787735130,"startTime":"0","endTime":"0","summary":"Adial Pharma grants unregistered option for 307,814 shares at $5.76 per shareAdial granted an unregistered inducement stock option for 307,814 common shares to a new employee on Aug. 19, 2026.Exercise price USD 5.76 per share; 10-year term.Vesting over four years: 25% after one year; remainder monthly, subject to continued service.Issued outside equity plans under Nasdaq Rule 5635; relying on Securities Act Section 4 and Regulation D.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 25, 2026, and is solely resp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7c9BTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662788752","title":"Adial Pharmaceuticals Grants Inducement Stock Options to New Hire","url":"https://stock-news.laohu8.com/highlight/detail?id=2662788752","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662788752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:57","pubTimestamp":1787691450,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) just unveiled an update. On August 19, 2026, Adial Pharmaceuticals granted a stock option to purchase 307,814 sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-grants-inducement-stock-options-to-new-hire?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-grants-inducement-stock-options-to-new-hire?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754923","title":"Adial Pharmaceuticals Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754923?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:05","pubTimestamp":1787688301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUA3NMPF6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440754","title":"Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440754","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440754?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:05","pubTimestamp":1787688300,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., Aug.  25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new em","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350874/0/en/adial-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662812206","title":"Adial Pharmaceuticals Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662812206","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662812206?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:07","pubTimestamp":1787602045,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals announces annual shareholder meetingAdial Pharmaceuticals will hold its annual stockholder meeting in Charlottesville, Virginia on Sept. 17, 2026.Votes include electing two Class","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL7Pw04F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661218965","title":"Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2661218965","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661218965?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:02","pubTimestamp":1787349724,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Adial Pharmaceuticals ( ($ADIL) ). On August 18, 2026, Adial Pharmaceuticals received a notice from Nasdaq that...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-faces-nasdaq-listing-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-faces-nasdaq-listing-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","ADIL","LCLG","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290167","title":"Adial Pharmaceuticals Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Minimum","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290167","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290167?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:18","pubTimestamp":1787347115,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals gets Nasdaq notice for falling below $2.5 million stockholders’ equity minimumAdial Pharmaceuticals received a Nasdaq notice on Aug. 18, 2026 for falling below the $2.5 million m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL1H34pT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adial.com","stockEarnings":[{"period":"1week","weight":0.1232},{"period":"1month","weight":-0.0297},{"period":"3month","weight":0.4101},{"period":"6month","weight":1.481},{"period":"1year","weight":-0.5631},{"period":"ytd","weight":-0.2873}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.058856},{"month":2,"riseRate":0.25,"avgChangeRate":-0.031808},{"month":3,"riseRate":0,"avgChangeRate":-0.155549},{"month":4,"riseRate":0.375,"avgChangeRate":-0.03424},{"month":5,"riseRate":0.375,"avgChangeRate":-0.002623},{"month":6,"riseRate":0.375,"avgChangeRate":-0.130351},{"month":7,"riseRate":0.625,"avgChangeRate":0.108193},{"month":8,"riseRate":0.222222,"avgChangeRate":0.014777},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.067367},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.138349},{"month":11,"riseRate":0.375,"avgChangeRate":0.139286},{"month":12,"riseRate":0.375,"avgChangeRate":0.00671}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}